Seemant Chaturvedi/ University of Maryland School of Medicine
Aug 6, 2025, 06:37
Seemant Chaturvedi: Could Tirofiban Improve Outcomes in Acute Ischemic Stroke?
NEJM Journal Watch has shared a post on X:
“Tirofiban as Thrombolysis Adjunct for Patients with Acute Ischemic Stroke
Patients might have benefited from tirofiban, although these findings require confirmation before clinicians change their practice.”
Read the full review article here.
Article: Tirofiban as Thrombolysis Adjunct for Patients with Acute Ischemic Stroke
Author: Seemant Chaturvedi, MD, reviewing Tao C et al. N Engl J Med 2025 Jul 3
Stay updated with latest scientific advancements on stroke with Hemostasis Today.
-
Jul 5, 2026, 22:51Shahzaib Akram: What Are We Actually Seeing When a Sickling Test Goes Positive?
-
Jul 5, 2026, 21:474 Tips for Exercising with A Bleeding Disorder – Haemophilia Foundation Australia
-
Jul 5, 2026, 21:06Heghine Khachatryan: Toward Personalized Management of Glanzmann Thrombasthenia
-
Jul 5, 2026, 21:06Priyanka Kumari: IV Fluids and Isotonic Solution
-
Jul 5, 2026, 21:05Ahmed Rizq: Would You Thrombolyse a Stable Patient?
-
Jul 5, 2026, 21:03Emmanuel Obeng Ofori: Diagnosing Anaemia – Why Treating the Root Cause Matters More Than Simply Raising the Haemoglobin
-
Jul 5, 2026, 21:02Mohit Koladia: The Pharmacist’s Role in Stroke Prevention for Atrial Fibrillation
-
Jul 5, 2026, 20:22J. Meireles-Brandao: Exploring the Approach to Thrombophillias
-
Jul 5, 2026, 20:13Kavya Keerthana: The Platelet Count Everyone Calls ‘Reactive’ Until It Isn’t